Literature DB >> 15220461

Lentiviral transduction of dendritic cells confers protective antiviral immunity in vivo.

Shohreh Zarei1, Shahnaz Abraham, Jean-Francois Arrighi, Olivier Haller, Thomas Calzascia, Paul R Walker, Thomas M Kündig, Conrad Hauser, Vincent Piguet.   

Abstract

Control of a viral infection in vivo requires a rapid and efficient cytotoxic-T-lymphocyte response. We demonstrate that lentivirus-mediated introduction of antigen in dendritic cells confers a protective antiviral immunity in vivo in a lymphocytic choriomeningitis virus model. Therefore, lentiviral vectors may be excellent vaccine candidates for viral infections.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15220461      PMCID： PMC434082          DOI： 10.1128/JVI.78.14.7843-7845.2004

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  21 in total

1.  Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes.

Authors:  J Dyall; J B Latouche; S Schnell; M Sadelain
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

2.  Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.

Authors:  D Valmori; V Dutoit; D Liénard; F Lejeune; D Speiser; D Rimoldi; V Cerundolo; P Y Dietrich; J C Cerottini; P Romero
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

Review 3.  Biology and pathogenesis of lymphocytic choriomeningitis virus infection.

Authors:  M B A Oldstone
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

4.  In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses.

Authors:  Christoph Esslinger; Laurence Chapatte; Daniela Finke; Isabelle Miconnet; Philippe Guillaume; Frédéric Lévy; H Robson MacDonald
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

5.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-04-19       Impact factor: 49.962

Review 6.  Immunological tolerance to viruses.

Authors:  M Volkert; J H Larsen
Journal:  Prog Med Virol       Date:  1965

7.  Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells.

Authors:  B Ludewig; S Oehen; F Barchiesi; R A Schwendener; H Hengartner; R M Zinkernagel
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

8.  Lentiviral vector-mediated tyrosinase-related protein 2 gene transfer to dendritic cells for the therapy of melanoma.

Authors:  P Metharom; K A Ellem; C Schmidt; M Q Wei
Journal:  Hum Gene Ther       Date:  2001-12-10       Impact factor: 5.695

9.  Transduction of dendritic cells by antigen-encoding lentiviral vectors permits antigen processing and MHC class I-dependent presentation.

Authors:  Shohreh Zarei; Florence Leuba; Jean-François Arrighi; Conrad Hauser; Vincent Piguet
Journal:  J Allergy Clin Immunol       Date:  2002-06       Impact factor: 10.793

10.  Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control.

Authors:  David W Mullins; Stacey L Sheasley; Rebecca M Ream; Timothy N J Bullock; Yang-Xin Fu; Victor H Engelhard
Journal:  J Exp Med       Date:  2003-10-06       Impact factor: 14.307
View more
  12 in total

Review 1.  Immunization delivered by lentiviral vectors for cancer and infectious diseases.

Authors:  Biliang Hu; April Tai; Pin Wang
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

Review 2.  Lentivirus as a potent and mechanistically distinct vector for genetic immunization.

Authors:  Yukai He; Louis D Falo
Journal:  Curr Opin Mol Ther       Date:  2007-10

Review 3.  Recombinant lentivector as a genetic immunization vehicle for antitumor immunity.

Authors:  Yukai He; David Munn; Louis D Falo
Journal:  Expert Rev Vaccines       Date:  2007-12       Impact factor: 5.217

4.  Highly efficient antiviral CD8+ T-cell induction by peptides coupled to the surfaces of liposomes.

Authors:  Akira Takagi; Masanori Matsui; Satoshi Ohno; Hongying Duan; Osamu Moriya; Nobuharu Kobayashi; Hiroshi Oda; Masahito Mori; Akiharu Kobayashi; Maiko Taneichi; Tetsuya Uchida; Toshitaka Akatsuka
Journal:  Clin Vaccine Immunol       Date:  2009-08-12

5.  Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation.

Authors:  Patrick Lacasse; Jérôme Denis; Réjean Lapointe; Denis Leclerc; Alain Lamarre
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

6.  Lentiviral vector-based prime/boost vaccination against AIDS: pilot study shows protection against Simian immunodeficiency virus SIVmac251 challenge in macaques.

Authors:  Anne-Sophie Beignon; Karine Mollier; Christelle Liard; Frédéric Coutant; Sandie Munier; Julie Rivière; Philippe Souque; Pierre Charneau
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

7.  Dendritic cell immunization route determines integrin expression and lymphoid and nonlymphoid tissue distribution of CD8 T cells.

Authors:  Stacey L Sheasley-O'Neill; C Colin Brinkman; Andrew R Ferguson; Melanie C Dispenza; Victor H Engelhard
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

8.  Virus-receptor mediated transduction of dendritic cells by lentiviruses enveloped with glycoproteins derived from Semliki Forest virus.

Authors:  Steven Froelich; April Tai; Katie Kennedy; Adnan Zubair; Pin Wang
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

9.  Alarmin augments the antitumor immunity of lentiviral vaccine in ectopic, orthotopic and autochthonous hepatocellular carcinoma mice.

Authors:  Zhili Liu; Zhen Lu; Renwei Jing; Bingfeng Zuo; Xianjun Gao; Gang Han; Han Qi; Li Wu; Yunde Liu; Haifang Yin
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

10.  Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine.

Authors:  Frédéric Coutant; Marie-Pascale Frenkiel; Philippe Despres; Pierre Charneau
Journal:  PLoS One       Date:  2008-12-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.